triazoles has been researched along with atazanavir sulfate in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (33.33) | 29.6817 |
| 2010's | 5 (55.56) | 24.3611 |
| 2020's | 1 (11.11) | 2.80 |
| Authors | Studies |
|---|---|
| Abel, S; Muirhead, GJ; Ridgway, CE; Russell, D; Taylor-Worth, RJ | 1 |
| Collins, C; Dickins, M; Hyland, R; Jones, B; Jones, H | 1 |
| Krishna, G; Ma, L; Martinho, M; McLeod, J; Moton, A; Seiberling, M | 1 |
| Fulco, PP; Gibson, JN | 1 |
| Craig, C; Fätkenheuer, G; Heera, J; Leal, M; McFadyen, L; Mildvan, D; Mills, A; Podzamczer, D; Portsmouth, S; Rinehart, AR; Than, S; Valdez, H; Valluri, SR; Vourvahis, M | 1 |
| Bertz, R; Furlong, M; Hanna, GJ; Hruska, M; Hwang, C; Landry, IS; Shah, V; Zhu, L | 1 |
| Augustijns, P; Brouwers, J; Elkhabaz, A; Moseson, DE; Taylor, LS | 1 |
| Gerisch, M; Jungmann, NA; Kaiser, A; Lentini, S; Radtke, M; Schulz, S; van der Mey, D; Yoshikawa, K | 1 |
4 trial(s) available for triazoles and atazanavir sulfate
| Article | Year |
|---|---|
Effects of CYP3A4 inhibitors on the pharmacokinetics of maraviroc in healthy volunteers.
Topics: Adolescent; Anti-HIV Agents; Antifungal Agents; Atazanavir Sulfate; CCR5 Receptor Antagonists; Cyclohexanes; Cytochrome P-450 CYP3A; Cytochrome P-450 CYP3A Inhibitors; Drug Interactions; Drug Therapy, Combination; Female; HIV Infections; HIV Protease Inhibitors; Humans; Ketoconazole; Male; Maraviroc; Middle Aged; Oligopeptides; Pyridines; Saquinavir; Statistics as Topic; Triazoles | 2008 |
Effects of oral posaconazole on the pharmacokinetics of atazanavir alone and with ritonavir or with efavirenz in healthy adult volunteers.
Topics: Administration, Oral; Adult; Alkynes; Anti-HIV Agents; Area Under Curve; Atazanavir Sulfate; Benzoxazines; Cross-Over Studies; Cyclopropanes; Drug Interactions; Female; Humans; Male; Middle Aged; Oligopeptides; Pyridines; Ritonavir; Triazoles | 2009 |
Maraviroc once-daily nucleoside analog-sparing regimen in treatment-naive patients: randomized, open-label pilot study.
Topics: Adenine; Adolescent; Adult; Aged; Anti-HIV Agents; Atazanavir Sulfate; CCR5 Receptor Antagonists; CD4 Lymphocyte Count; Cyclohexanes; Deoxycytidine; Drug Therapy, Combination; Emtricitabine; Female; HIV Fusion Inhibitors; HIV Infections; HIV-1; Humans; Male; Maraviroc; Middle Aged; Oligopeptides; Organophosphonates; Pilot Projects; Pyridines; Ritonavir; RNA, Viral; Tenofovir; Triazoles; Viral Load; Young Adult | 2013 |
Pharmacokinetic interactions between BMS-626529, the active moiety of the HIV-1 attachment inhibitor prodrug BMS-663068, and ritonavir or ritonavir-boosted atazanavir in healthy subjects.
Topics: Adolescent; Adult; Anti-HIV Agents; Atazanavir Sulfate; Cross-Over Studies; Drug Interactions; Drug Therapy, Combination; Female; HIV Envelope Protein gp120; HIV Fusion Inhibitors; HIV-1; Humans; Male; Middle Aged; Organophosphates; Piperazines; Ritonavir; Triazoles; Young Adult | 2015 |
5 other study(ies) available for triazoles and atazanavir sulfate
| Article | Year |
|---|---|
Maraviroc: in vitro assessment of drug-drug interaction potential.
Topics: Area Under Curve; Atazanavir Sulfate; Cyclohexanes; Cytochrome P-450 CYP3A; Drug Interactions; HIV Infections; HIV Protease Inhibitors; HIV-1; Humans; Ketoconazole; Liver; Male; Maraviroc; Microsomes, Liver; Oligopeptides; Predictive Value of Tests; Pyridines; Ritonavir; Saquinavir; Triazoles | 2008 |
Concurrent atazanavir and voriconazole in a patient with multidrug-resistant HIV and a mycetoma.
Topics: AIDS-Related Opportunistic Infections; Anti-HIV Agents; Antifungal Agents; Atazanavir Sulfate; Drug Resistance, Multiple, Viral; Humans; Male; Middle Aged; Mycetoma; Oligopeptides; Pyridines; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole | 2011 |
News drugs and dosage forms.
Topics: Anti-HIV Agents; Antifungal Agents; Atazanavir Sulfate; Drug Combinations; Humans; Ketorolac; Oligopeptides; Phenylephrine; Pyridines; Testosterone; Triazoles | 2014 |
Interplay of Supersaturation and Solubilization: Lack of Correlation between Concentration-Based Supersaturation Measurements and Membrane Transport Rates in Simulated and Aspirated Human Fluids.
Topics: Atazanavir Sulfate; Biological Transport; Body Fluids; Chemistry, Pharmaceutical; Crystallization; Diffusion; Humans; Kinetics; Solubility; Thermodynamics; Triazoles | 2019 |
Drug-drug interaction of atazanavir on UGT1A1-mediated glucuronidation of molidustat in human.
Topics: Adult; Atazanavir Sulfate; Drug Interactions; Erythropoietin; Glucuronides; Glucuronosyltransferase; Humans; Male; Middle Aged; Pyrazoles; Triazoles; Young Adult | 2021 |